Fimbrial protein A (FimA)

Fimbrial protein A (FimA) is the principal structural subunit of bacterial type 1 (and in some species, type V) fimbriae or pili, which are filamentous protein appendages radiating from the cell surface of many Gram-negative and some Gram-positive bacteria[1][2][5][6][7]. FimA monomers polymerize to form the backbone of these pili, with up to thousands of subunits assembling via donor strand complementation or exchange mechanisms to yield highly stable, adhesive fibers[6][7]. These structures mediate critical processes such as bacterial adhesion to host tissues, colonization, biofilm formation, and are directly implicated in the pathogenicity of several bacteria, including Escherichia coli (notably uropathogenic E. coli), Porphyromonas gingivalis (a major etiologic agent in periodontitis), and Actinomyces species (important in dental plaque)[2][3][5][6][7]. FimA expression enables bacteria to efficiently attach to and colonize epithelial/other surfaces, form robust biofilms, and resist mechanical or fluid shear forces[2][5]. While FimA itself is not a receptor, enzyme, or classical drug target, it is foundational for bacterial virulence, and disabling FimA-mediated adhesion or pilus assembly is a focus of antimicrobial research, although no approved drugs currently act directly on FimA[5][6][7]. There are multiple FimA genotypes/variants in clinically relevant bacteria, which can influence binding specificity and epidemiological subtyping[3][4].

Other names

fimAtype 1 fimbrial subunit proteintype I pilintype 1A pilinfimbrillinpilAb4314JW4277type V pilin (in Porphyromonas gingivalis)fimbrial subunit FimA

No approved drugs; theoretical mechanisms include inhibition of pilus assembly, interference with FimA polymerization, or blocking FimA-mediated adhesion